U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07234526) titled 'Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients' on Sept. 17.
Brief Summary: To determine whether glucose fluctuations prior to antibiotic administration are associated with sepsis severity and poor clinical outcomes.
* To assess if the time to Glycemic Normalization after Antibiotic Initiation can be used as an Early Prognostic Indicator in Sepsis.
* To evaluate the Glycemic Shock Index (GSI) as a Combined Marker of Hemodynamic and Metabolic Stress in ICU Sepsis Patients.
Study Start Date: Dec. 01, 2026
Study Type: OBSERVATIONAL
Condition:
Glucose Fluctuations in Sepsis
Recruitment Status: NOT_Y...